ALEXANDRIA, Va., Feb. 24 -- United States Patent no. 12,559,553, issued on Feb. 24, was assigned to Gilead Sciences Inc. (Foster City, Calif.).
"IL-31 modulators for treating FXR-induced pruritus" was invented by Andrew Nicholas Billin (San Mateo, Calif.) and Jun Xu (Foster City, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates generally to methods of using modulators of interleukin-31 (IL-31) for treating, stabilizing, or lessening the severity or progression of pruritis."
The patent was filed on June 17, 2022, under Application No. 17/843,232.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PT...